| | 654653-93-7 Basic information More.. |
| Product Name: | (αR,βS)-rel-Bedaquiline | | Synonyms: | (1R,2S)-rac-1-(6-bromo-2-methoxyquinolin-3-yl)-4-(methylamino)-2-(naphthalen-1-yl)-1-phenylbutan-2-ol;cis-1-(6-Bromo-2-methoxyquinolin-3-yl)-4-(dimethylamino)-2-(naphthalen-1-yl)-1-phenylbutan-2-ol;(αR,βS)-rel-6-Bromo-α-[2-(dimethylamino)ethyl]-2-methoxy-α-1-naphthalenyl-β-phenyl-3-quinolineethanol;3-Quinolineethanol, 6-bromo-α-[2-(dimethylamino)ethyl]-2-methoxy-α-1-naphthalenyl-β-phenyl-, (αR,βS)-rel-;Bedaquiline (1R,2S)Isomer;(AlphaR,BetaS)-rel-Bedaquiline;Bedaquiline Fumarate Impurity 40;Glycerol Impurity 108 | | CAS: | 654653-93-7 | | MF: | C32H31BrN2O2 | | MW: | 555.5 | | EINECS: | | | Mol File: | 654653-93-7.mol |  |
Use
(αR,βS)-rel-Bedaquiline is a promising diarylquinoline candidate in clinical development for the treatment of tuberculosis. (αR,βS)-rel-Bedaquiline inhibits mycobacterial ATP synthase and displays high activity against both drug-susceptible and multidrug-resistant strains of Mycobacterium tuberculosis.
|
|
654653-93-7
Recommend Suppliers |
|